businesspress24.com - Calyx to Acquire Additional Software Assets
 

Calyx to Acquire Additional Software Assets

ID: 1468292

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/07/16 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to announce that it has entered into a letter of intent to acquire the rights to an existing software framework which will enhance the features of our real-time, mass communications platform. The new framework provides the additional flexibility to aggregate users onto a single forum, and at the same time allow them to participate in specialized forums or communicate privately. This technology is expected to seamlessly integrate into the Company''s existing FocusPoint Software Platform, which forms the basis of the Company''s LEAFHub Communications Cloud product.

In consideration for the acquisition, the Company will issue 2,500,000 common shares and will complete cash payments of (Cdn) $200,000 over a twelve-month term.

Completion of the transaction remains subject to due diligence, the approval of the TSX Venture Exchange, and certain other conditions customary in transactions of this nature. The transaction cannot be completed until these conditions are satisfied.

About Calyx

Calyx''s wholly-owned subsidiary, Cannigistics Agri-Solutions Corp., is a software development company that has created a software platform tailored to advanced indoor agriculture. The Cannigistics software platform is designed to enhance the efficiency and effectiveness of indoor agricultural operations, and positions Cannigistics to be the industry leader in agri-software solutions by providing businesses with advanced controls over all aspects of their operations. Additionally, Calyx owns a portfolio of proprietary intellectual property with applications in crop enhancement.

For further information about Calyx, please visit .

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.







Contacts:
Calyx Bio-Ventures Inc.
Roger Forde
President and Chief Executive Officer
604.880.8822

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Aldeyra Therapeutics Announces Presentation of Phase 2 Allergic Conjunctivitis Results at the 2016 American College of Allergy, Asthma and Immunology Annual Scientific Meeting
CORRECTION - Flamel Technologies Reports Third Quarter 2016 Results
Bereitgestellt von Benutzer: Marketwired
Datum: 07.11.2016 - 07:00 Uhr
Sprache: Deutsch
News-ID 1468292
Anzahl Zeichen: 4166

contact information:
Contact person:
Town:

VANCOUVER, BRITISH COLUMBIA


Phone:

Kategorie:

Biotech


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 155 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Calyx to Acquire Additional Software Assets
"
steht unter der journalistisch-redaktionellen Verantwortung von

Calyx Bio-Ventures Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Calyx Bio-Ventures Inc.



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 174


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.